Publications by authors named "Mu-Kuo Wang"

Claim this Profile
I
Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity.
Xiaojie Chen, Long-Fei Mao, Siqi Tian, Xueli Tian, Xueqiong Meng, Mu-Kuo Wang

Front Pharmacol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ursolic acid reduces hepatocellular apoptosis and alleviates alcohol-induced liver injury via irreversible inhibition of CASP3 in vivo.
Xiao-Yao Ma, Man Zhang, Ge Fang, Chuan-Jing Cheng, Mu-Kuo Wang

Acta Pharmacol Sin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis